Core Viewpoint - Guichuang Tongqiao Medical Technology Co., Ltd. reported strong financial performance for the first half of 2025, with significant growth in both revenue and net profit [1] Financial Performance - The company achieved a revenue of 482 million yuan, representing a year-on-year increase of 31.7% [1] - Net profit exceeded 121 million yuan, showing a year-on-year growth of 76% [1] Business Segments - The neurovascular intervention segment generated approximately 304 million yuan in revenue, reflecting a year-on-year growth of 25% [1] - The peripheral vascular intervention segment reported revenue of about 176 million yuan, with a year-on-year increase of 46.2% [1] International Operations - Overseas business generated revenue of 15.72 million yuan, with 22 products commercialized in 27 countries and regions [1] - The company is advancing the registration of over 31 products in 23 countries and regions, with global coverage in 52 countries and regions [1] - Collaborations have been established with more than 60 local partners [1]
归创通桥上半年净利润增长76%，22款产品在海外实现商业化